Index
| Measure ID |
Title |
eMeasure ID |
Measure Type |
NQF ID |
High Priority |
Submission Methods |
Risk Adjusted? |
Registry Measure? |
|
ACS17
|
Preoperative Key Medications Review for Anticoagulation Medication
|
|
Process |
|
|
|
|
|
|
ACS18
|
Patient Frailty Evaluation
|
|
Process |
|
|
|
|
|
|
ACS19
|
Intraoperative Composite
|
|
Outcome |
|
|
|
|
|
|
ACS20
|
Optimal Postoperative Communication Plan and Patient Care Coordination Composite
|
|
Outcome |
|
|
|
|
|
|
ACS21
|
Post-Acute Recovery Composite
|
|
Outcome |
|
|
|
|
|
|
ACS22
|
Unplanned Reoperation within the 30 Day Postoperative Period
|
|
Outcome |
|
|
|
|
|
|
ACS23
|
Unplanned Hospital Readmission within 30 Days of Principal Procedure
|
|
Outcome |
|
|
|
|
|
|
AHSQC1
|
Ventral Hernia Repair: Surgical Site Occurrence Requiring Procedural Intervention within the 30 Day Postoperative Period
|
|
Outcome |
|
|
|
|
|
|
AHSQC2
|
Unplanned Hospital Readmission or Observation Visit within the 30 Day Postoperative Period
|
|
Outcome |
|
|
|
|
|
|
AHSQC6
|
Abdominal Wall Reconstruction Surgical Site Occurrence Requiring Procedural Intervention within the 30 Day Postoperative Period
|
|
Outcome |
|
|
|
|
|
|
AHSQC7
|
Abdominal Wall Reconstruction Preoperative Diabetes Assessment
|
|
Process |
|
|
|
|
|
|
AHSQC8
|
Ventral Hernia Repair: Biologic Mesh Prosthesis Use in Low Risk Patients
|
|
Efficiency |
|
|
|
|
|
Page 14 of 75